Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Wiener Medizinische Wochenschrift (1946)|June 30, 1989
[Clinical study comparing the effectiveness and tolerance of 2 current and one new glibenclamide formulation]G Lingg, A Haushofer
Wiener Medizinische Wochenschrift (1946)|January 1, 1993
[Prothrombin fragment 1+2 (F1+2), thrombin-antithrombin III complex(TAT) and thrombophilia parameters in orally anticoagulated patients with inferior vena cava filters]W M Halbmayer, A Haushofer, E Toth
Wiener Medizinische Wochenschrift (1946)|January 1, 1991
[Automation in the modern coagulation laboratory. Exemplified by the integration of the Microanalyser ACL 300]A Haushofer, W M Halbmayer, M Fischer
Hamostaseologie|May 11, 2010
[The importance of preanalytics for the coagulation laboratory]Georg Endler, G Slavka, T Perkmann, et al.
Wiener Medizinische Wochenschrift (1946)|January 1, 1993
[Preoperative monitoring of blood coagulation in urologic operations: diagnosis of familial factor XI deficiency within the scope of preoperative blood coagulation studies]A Haushofer, W M Halbmayer, E Toth, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 1, 1994
The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjectsW M Halbmayer, A Haushofer, R Schön, et al.
Angiology|April 1, 1995
Quality assurance of high-dose i.v. heparin treatment exemplified by patients implanted with coronary Palmaz-Schatz stentsA Haushofer, W M Halbmayer, H Prachar, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 24, 1999
Venous thromboembolism at a young age in a brother and sister with coinheritance of homozygous 20210A/A prothrombin mutation and heterozygous 1691G/A factor V Leiden mutationW M Halbmayer, T Kalhs, A Haushofer, et al.
Haemostasis|May 1, 1995
Comparison of a new automated kinetically determined fibrinogen assay with the 3 most used fibrinogen assays (functional, derived and nephelometric) in Austrian laboratories in several clinical populations and healthy controlsW M Halbmayer, A Haushofer, R Schön, et al.
Clinical Immunology and Immunopathology|October 1, 1992
Indications for the presence of antibodies cross-reactive with HTLV-I/II, but not HIV, in patients with myelodysplastic syndromeM Möstl, H Mucke, M Schinkinger, et al.
Pageof 2